Marksans Pharma Limited ( MARKSANS.NS) - Key Metrics
MARKSANS.NS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2027Q2 | ₹20.75 | ₹3.12 | ₹0 | ₹0 |
| 2027Q1 | ₹18.55 | ₹3.47 | ₹0 | ₹0 |
| 2026Q4 | ₹18.90 | ₹3.27 | ₹0 | ₹0 |
| 2026Q3 | ₹16.66 | ₹2.50 | ₹0 | ₹0 |
| 2026Q2 | ₹15.91 | ₹2.17 | ₹1.66 | ₹0.04 |
MARKSANS.NS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2027Q2 | 28.86% | 25.83 |
| 2027Q1 | 0% | 19.65 |
| 2026Q4 | 0% | 11.99 |
| 2026Q3 | 0% | 18.03 |
| 2026Q2 | 36.90% | 19.01 |
MARKSANS.NS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2027Q2 | 0% | 0.28% |
| 2027Q1 | 0% | 0% |
| 2026Q4 | 0% | 0% |
| 2026Q3 | 0% | 0% |
| 2026Q2 | 0.03% | 0.49% |
MARKSANS.NS
Price: ₹291.15
52 week price:
Forward Dividend Yield: 0.31%
Payout Ratio: 8.16%
Payout Ratio Range:
Dividend Per Share: 0.90 INR
Earnings Per Share: 12.35 INR
P/E Ratio: 25
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 139.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 13